4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid, CV-11974, B in
) occurs (1, 2) .
Impurities in an active pharmaceutical ingredient (API) decrease its safety and quality and, according to the International Council for Harmonisation, they are generally classified as organic and inorganic compounds and residual solvents. Their detection and evaluation of their risk level is a necessity in the development of a safe and effective drug. However, complete elimination of both the process-related and degradation impurities is a mission impossible to accomplish, no matter how strict the regulatory requirements are (3) . A very important role in impurity level control is that of activities at intermediate stages.
Appropriate preventive actions ensure higher quality of upcoming intermediates and of the final API. Especially hot topics are the genotoxic alerting compounds, for which additional attention is required (4) . Liquid chromatography coupled with mass spectrometry and analogue techniques are among most popular tools for impurity and drug product characterization because of their capability of reliable structural elucidation (5) .
Knowledge about impurities contributes to an improved and optimized effective synthetic process of selected API. It is known from the literature that eight degradation impurities of candesartan cilexetil were discovered using LC-MS-TOF and it was proven that most of them arose under neutral conditions of hydrolysis and photolytic conditions (6) . Impurities were isolated and their structures were confirmed by NMR spectroscopy. In another report, a process impurity of candesartan cilexetil was described and a selective method for its assay was proposed (7) . Moreover, during target synthesis an API related substance, formed via intermolecular N-alkylation, was observed (7). Also, syntheses of very common intermediates for TCV-116 and its desethyl, desethoxy and methyl analogues were published (8) . Purity of intermediates turned out to be essential for the subsequent steps of drug synthesis and its yield. A potentially genotoxic impurity, cilexetil chloride, was also discovered with a selective GC/MS analytical method in the API (9).
During our synthesis of TCV-116, a novel process-related impurity (D, Fig. 1 ) was discovered during developmental studies of a key intermediate (C , Fig. 1 ). 1-Chloroalkyl carbonate ester analogue (D, Fig. 1 ) of the intermediate (C , Fig. 1 ) was obtained. Based on previous studies, chlorine, as a part of the functional group with aliphatic chain, could be a genotoxic alerting compound (10) . Through further target mass precursor examination, it was found that the impurity appeared after esterification reaction of trityl candesartan (7, Scheme 1) with halogenated cyclohexyl carbonate (in most cases 1-chloroethyl cyclohexyl carbonate E, Scheme 1), which had already been identified as hazardous (9) . It is therefore very important to control each stage of the synthesis and develop a synthesis procedure to minimize the formation of impurities.
Scheme 1 EXPERIMENTAL

Reagents
HPLC gradient grade solvents: acetonitrile, methanol, acetone, dichloromethane, isopropyl acetate and tetrahydrofuran, and LC/MS grade chemicals: ammonium formate, ammonium acetate, formic acid and acetic acid were purchased from Merck (Germany). Purified water, prepared using a Milli-Q Plus purification system (Millipore, USA) was used throughout the studies. Deuterated chloroform for NMR measurements was delivered from Sigma Aldrich (Germany). Starting materials for target synthesis, acetaldehyde and 1-chloroethyl chloroformate, were purchased from Sigma Aldrich. Reaction solvent 1,2-dichloroethane was purchased from Kemika (Croatia). Potassium carbonate and magnesium sulphate were purchased from Merck.
Gas chromatography coupled with mass spectrometry
For GC screening of the product isolated in two-step synthesis, the 7890A GC System, Agilent Technologies, coupled with a 5975C Inert XL EI/CI MSD mass spectrometer including a Triple-Axis detector was used (Agilent Technologies, USA). Chromatographic separations were run on a DB-WAX column, 30 m × 0.32 mm, 0.25 µm (Agilent Technologies). Helium was used as carrier with a flow rate of 2 mL min -1 and nitrogen as makeup gas at a flow rate of 25 mL min -1
. Injector temperature was set to 140 °C and detector temperature to 250 °C. Temperature programme started at 100 °C with an increasing rate of 10 °C min 
Liquid chromatography coupled with mass spectrometry
For HPLC analysis, a liquid chromatograph 1290 UHPLC (Agilent Technologies) and Vanquish UHPLC system (Thermo Scientific, USA), resp., equipped with a binary gradient pump, degasser, autosampler, column thermostat and diode array detector were utilized. Instruments were controlled via HyStar™ 3.2 (Bruker Daltonics, USA) and XCalibur™ software (Thermo Scientific), resp. Chromatographic separations were run on two columns: Zorbax XDB C18+ 50 mm × 4.6 mm i.d., 1.8 µm particles (Agilent Technologies) and Accucore Vanquish C18 100 mm × 2.1 mm i.d., 1.5 µm particles (Thermo Scientific). Aqueous mobile phase, 10 mmol L -1 ammonium acetate (pH = 7.0), and organic mobile phase, acetonitrile, were used in a gradient mode: the initial mobile phase with 5 % acetonitrile linearly changed in 20 min to a mobile phase containing 98 % of acetonitrile and remained constant for 5 min. Flow rate was set to 0.7 on Zorbax and to 0.1 mL min -1 on Vanquish column and analyses were performed at room temperature. Injection volume was 2 µL and autosampler temperature was set to 10 °C. Detection was performed at the wavelength of 230 nm. Samples (approximate concentration 0.3 mg mL -1 ) were dissolved in tetrahydrofuran and diluted with acetonitrile to the final volume.
Mass spectrometer was coupled with the liquid chromatograph via a splitter at a 10:1 ratio. Mass measurements were carried out on a MaXis Impact™ mass spectrometer (Bruker Daltonics, USA) and LTQ Orbitrap XL™ (Thermo Scientific), resp. Ionization was performed by electrospray using a Maxis instrument (ESI) and heated electrospray ion source on an LTQ Orbitrap mass spectrometer (hESI). Time of flight analyzer (MaXis Impact) with a dual ion funnel, quadrupole, high transmission CID cell and flight tube with a dual stage reflector was applied. Long life lash detector enabled ultra-fast acquisition speed up to 50 Hz and high mass accuracy across the entire mass range. Mass spectrometer was controlled via the otof Control 5.3.14.0 program and data were evaluated with Compass Data Analysis 4.1 (Bruker Daltonics GmbH Software, USA). N 2 was a sheath and auxiliary gas, source voltage was set to 4.5 kV and capillary temperature at 250 °C, dry gas was set to 8 mL min -1 and nebulizer to 1.5 bars. Generated ions were detected with a quadrupole. Ion transfer was taken in 80-120 µs range and pre-pulse storage time in 8-12 µs range. Funnel RF 1 and 2 were set to 250 V p-p . Mass range m/z from 100 to 2000 with rolling (moving) average 2 was included. Fragmentation MS/MS studies were performed at normalized collision energy from 25 to 40.7 eV.
LTQ Orbitrap XL™ hybrid Ion Trap-Orbitrap mass spectrometer, as a matter of fact Fourier transform mass spectrometer (FTMS) based on Thermo Scientific™ LTQ XL™ linear ion trap, and Orbitrap mass spectrometer technologies with an HCD collision cell for advanced research were controlled with XCalibur™ software and with LTQ Tune 3.2.2 (Thermo Scientific). Heated electrospray was set to 320 °C and capillary voltage to 45 V. Sheath gas was set to 55 and auxiliary gas to 7 mL min 
Syntheses of reference materials
Synthesis of bis (1-chloroethyl) carbonate (compound F). -Synthesis was performed on the basis of 1-haloalkyl carbonate synthesis described in the literature (11) . A catalytic amount of pyridine (4.97 mmol, 0.4 mL) was added to a stirred solution of 1-chloroethyl chloroformate (9.3 mmol, 1.0 mL) and acetaldehyde (14.3 mmol, 0.8 mL) in 1,2-dichloroethane (10.0 mL). Solution was then heated to 80 °C for 4 h. When the reaction was completed, the mixture was cooled down to room temperature and water was added (15 mL). Layers were separated and water fractions were extracted with dichloromethane (10 mL). Combined organic layers were dried with anhydrous MgSO 4 and filtered. Final product was obtained by vacuum evaporation. Structure of the main product was determined via GC-MS.
Synthesis of 1-(((1-chloroethoxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate (compound D).
-To a solution of potassium carbonate in dimethylacetamide (110 mg mL
imidazole-7-carboxylic acid (0.30 mmol, 0.20 g) and bis(1-chloroethyl) carbonate (F, Scheme 1) (0.30 mmol, 0.05 g) were added and the reaction mixture was heated for 3 h at 60 °C. The reaction mixture was then cooled to room temperature and washed with isopropyl acetate (10 mL) and then water (10 mL). Combined organic phases were dried with anhydrous MgSO 4 and filtered. Raw material was obtained by vacuum evaporation. To an oil residue, diethyl ether was added and left under stirring overnight. Crude product was obtained by vacuum evaporation. At the end, the oiled residue was left to macerate in hexane for about 1 h. A suspension was formed and then the product was filtered. Purity and authenticity of the product were determined by LC-MS.
Semi-preparative HPLC
Impurity compound D (Fig. 1) was isolated using the 1200 prepHPLC system with a binary gradient pump, UV detector, autosampler hyphenated to a MSD G6130A single quad mass spectrometer (Agilent Technologies). Instrument was controlled with ChemStation Software 4.03 (Agilent Technologies). Preparation column Luna C18, 150 mm × 21.2 mm i.d., 5 µm particles (Phenomenex, USA), was used at 30 °C. The same gradient mobile phase was used as described previously at a flow rate of 44 mL min -1 in 100:1 split ratio to a MSD mass spectrometer. Samples (approximate concentration 100 mg mL ) were prepared by dissolving a sample in a small volume of tetrahydrofuran, and then acetonitrile was added to the final volume. Injection volume was 100 mL and UV detection was monitored at 230 nm. Fractions of target impurity were collected at retention times around 23 min and the impurity was back extracted with dichloromethane. Organic phases were collected and dried with MgSO 4 . Suspension was filtered and the solvent was removed by vacuum evaporation. Structure of the isolated substance was confirmed by NMR and LC-ESI-MS. 
NMR spectroscopy
1D and 2D NMR experiments were performed on a 400 MHz Varian NMR spectrometer (Varian, USA) at 25 °C. All spectra were acquired for samples dissolved in CDCl 3 . 1 H and 13 C chemical shifts (d, ppm) were reported relative to TMS as internal standard.
RESULTS AND DISCUSSION
As every stage of API synthesis should be evaluated, HPLC analyses of the key intermediate C in the synthesis of A were performed (Fig. 1) . In HPLC chromatograms (Fig. 2) , after injection of trityl carboxylate solution C (Fig. 1) , two unknown peaks (X and Y) between 11.7 and 11.9 min were observed. Mass spectra showed that both peaks had the same m/z value of 833 with additional adduct ions, for example, [M+Na] + with m/z 855 and [M+K]
+ with m/z 871 confirming m/z of the molecular ion (Fig. S1 ). MS 2 spectra of both peaks showed the same fragmentation and isotope pattern and the presence of chlorine could be indicated. According to exact mass measurements, UV spectra and ion fragmentation spectra via a qTOF high resolution analyzer, C 48 H 42 ClN 6 O 6 + chemical formula for the [M+H] + ion was proposed and can be assigned to chloroalkyl carbonate ester impurity D (Fig. 1) . This compound has a chiral centre in the structure and therefore a diastereoisomeric mixture was expected and two peaks in the LC-MS chromatogram can be explained. From the proposed impurity structure and regarding the route of synthesis presented in Scheme 1, no detection of impurity before the last step of the synthetic route is expected.
Target mass search confirmed this hypothesis as impurity precursor was not found at previous steps of the synthesis. Moreover, synthon, as bis(1-chloroethyl) carbonate (F, Scheme 1) instead of 1-chloroethyl cyclohexyl carbonate (E, Scheme 1), which was utilized in esterification reaction, was estimated to be present and to cause impurity formation.
In addition, traces of bis(1-chloroethyl) carbonate (F, Scheme 1) were detected via GC-MS (Fig. S2 ) in 1-chloroethyl cyclohexyl carbonate (E, Scheme 1) and correlation between bis(1-chloroethyl) carbonate (F, Scheme 1) and final chloroalkyl carbonate ester impurity (D, Fig. 1 ) was observed (R = 0.99; significance at a = 0.05). According to a noticeable trend, we also confirmed that the impurity did not increase during the esterification reaction, but was formed due to the bis(1-chloroethyl) carbonate F presence. Reagent F was formed during the synthesis (Scheme 1) and apparently under such reaction conditions partial dimerization of 1-chloroethyl chloroformate to bis(1-chloroethyl) carbonate (F, Scheme 1) could occur.
To investigate in detail the occurrence of impurity D (Fig. 1) , a target two-step synthesis was performed. The first step was target synthesis of reagent F according to the synthesis of 1-haloalkyl carbonates described in the literature (11). F is not commercially available and represents the main starting compound in the second step where esterification reaction of crude trityl candesartan acid intermediate 7 (Scheme 1) led to formation of chloroalkyl ester impurity D (Fig. 1) as the main compound. Synthesis was performed under the same conditions as the synthesis of key intermediate C, except for bis(1-chloroethyl) carbonate F, which was used instead of 1-chloroethyl cyclohexyl carbonate E. Crude product containing about 30 % of chloroalkyl ester D (Fig. 1) was isolated via preparative chromatography (Fig. S3) . According to mass spectrometric data (Fig. S5) , structures of two peaks with similar retention times (Fig. S4) were confirmed in isolated material. In the MS full scan spectrum of impurity D (Fig. 1) , a large peak at m/z = 243 was observed and some other small peaks beside the molecular ion and its adducts (Table I, Fig. S6 ). Exact mass data indicated that the trityl group was not stable during ion formation. Further investigation showed that settings of the ion source (e.g., temperature) influenced the degradation of this substance during MS scan. For example, during hESI+ ionization (temperatures higher than 300 °C), fragment [ (ordinary temperatures) generates the same fragment of m/z 805 during the ionization process with lower intensity and it may be assumed that ion source temperature considerably influences the substance degradation during ionization.
In general, there are no conditions in ion source that could prevent fragmentation of the labile trityl group as m/z 243 appears with every modification of ionization parameters. Based on this knowledge, fragmentation in ion source is proposed in Scheme 2.
Basic fragment in the MS
2 spectrum confirmed the presence of trityl ion, other fragments are less intensive and therefore structure interpretation is complicated. Consequently, for structure identification, the part of the molecule without trityl group (Fig. S7) , (6) . Theoretical calculations showed that protonated sartans and the related analogues tend to form N-substituted-3-substituted phenanthridin-6-amine ion, which has a large conjugated structure; therefore, six-membered ring structures of fragments after neutral loss of N 2 or CO 2 (13) can be proposed. In the literature, relative Gibbs free energies of precursor and product ions were calculated using the density functional theory. In accordance with the calculations, six-membered ring structures of the fragments appear to be thermodynamically the most stable ones (Fig. 3) . According to the MS 2 spectrum of both chromatographic peaks, we could confirm two isomers, since no difference was found in the fragmentation spectrum. In contrast to the MS spectrum, the intensity of fragments does not vary according to different fragmentation energy, possibly due to preliminary decomposition during ionization.
To confirm the structure of impurity D, NMR analyses of isolated material were performed. Complete proton and carbon chemical shift assignments with atom labelling are given in Table III and Fig. 4 . Two sets of signals are observed in the spectra (Fig. S9) and consequently the diastereoisomeric mixture of impurity D can be confirmed. Signals at 1.75 and 1.80 ppm (doublets) match the methyl groups and are coupled to downfield shifted signals at 6.38 and 6.40 ppm (quartets).
13 C chemical shifts at 84.60 and 84.69 ppm (Fig.  S10) are deshielded due to the presence of heteroatoms (oxygen and chlorine). Aromatic proton at 7.86 ppm shows correlation with tetrazole carbon at 164.02 ppm, identifying the trityl substituent at N-2 position of tetrazole ring (2D HMBC experiment, Fig. S11 ) (14) . . Two diastereoisomers of D were identified on the basis of mass and NMR spectra. In the course of further investigation and target synthesis, it was found that bis(1-chloroethyl) carbonate (F) was the precursor for impurity formation. In order to assure quality and safety of the key intermediate and consequently of the final API, it was very important to keep compound F at low level during synthesis. According to these results and implementation of synthetic strategy, where the identified impurity did not appear, either at the intermediate stage or in final API, the above detection limit of 50 mg L -1 could be achieved. The present study offers an important contribution to structural investigation of impurities related to TCV-116 and consequently to the synthetic design of selected API.
